These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30100727)

  • 1. Angiotensin II: a new therapeutic option for vasodilatory shock.
    Bussard RL; Busse LW
    Ther Clin Risk Manag; 2018; 14():1287-1298. PubMed ID: 30100727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock.
    Bellomo R; Wunderink RG; Szerlip H; English SW; Busse LW; Deane AM; Khanna AK; McCurdy MT; Ostermann M; Young PJ; Handisides DR; Chawla LS; Tidmarsh GF; Albertson TE
    Crit Care; 2020 Feb; 24(1):43. PubMed ID: 32028998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Effective is Angiotensin II in Decreasing Mortality of Vasodilatory Shock? A Systematic Review.
    Semedi BP; Rehatta NM; Soetjipto S; Nugraha J; Mahyuddin MH; Arnindita JN; Wairooy NAP
    Open Access Emerg Med; 2023; 15():1-11. PubMed ID: 36636460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature.
    Busse LW; McCurdy MT; Ali O; Hall A; Chen H; Ostermann M
    Crit Care; 2017 Dec; 21(1):324. PubMed ID: 29282149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of renin-angiotensin system in sepsis-associated acute kidney injury: mechanisms and therapeutic implications.
    Garcia B; Zarbock A; Bellomo R; Legrand M
    Curr Opin Crit Care; 2023 Dec; 29(6):607-613. PubMed ID: 37861190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II in Decompensated Cirrhosis Complicated by Septic Shock.
    Coleman PJ; Nissen AP; Kim DE; Ainsworth CR; McCurdy MT; Mazzeffi MA; Chow JH
    Semin Cardiothorac Vasc Anesth; 2020 Sep; 24(3):266-272. PubMed ID: 31540560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial.
    Bellomo R; Forni LG; Busse LW; McCurdy MT; Ham KR; Boldt DW; Hästbacka J; Khanna AK; Albertson TE; Tumlin J; Storey K; Handisides D; Tidmarsh GF; Chawla LS; Ostermann M
    Am J Respir Crit Care Med; 2020 Nov; 202(9):1253-1261. PubMed ID: 32609011
    [No Abstract]   [Full Text] [Related]  

  • 8. A Multicenter Observational Cohort Study of Angiotensin II in Shock.
    Smith SE; Newsome AS; Guo Y; Hecht J; McCurdy MT; Mazzeffi MA; Chow JH; Kethireddy S
    J Intensive Care Med; 2022 Jan; 37(1):75-82. PubMed ID: 33231111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications.
    Wolf G; Ritz E
    Kidney Int; 2005 Mar; 67(3):799-812. PubMed ID: 15698420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II in Vasodilatory Shock.
    Wakefield BJ; Busse LW; Khanna AK
    Crit Care Clin; 2019 Apr; 35(2):229-245. PubMed ID: 30784606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II in Refractory Septic Shock.
    Antonucci E; Gleeson PJ; Annoni F; Agosta S; Orlando S; Taccone FS; Velissaris D; Scolletta S
    Shock; 2017 May; 47(5):560-566. PubMed ID: 27879559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II.
    Zhuo JL; Li XC
    Peptides; 2011 Jul; 32(7):1551-65. PubMed ID: 21699940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
    Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
    Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II in septic shock.
    Jadhav AP; Sadaka FG
    Am J Emerg Med; 2019 Jun; 37(6):1169-1174. PubMed ID: 30935784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catecholamine-Sparing Effect of Angiotensin II in an Anephric Patient With Mixed Shock After Cardiac Revascularization Surgery: A Case Report.
    Cutler NS; Khanna AK
    A A Pract; 2020 Jul; 14(9):e01266. PubMed ID: 32909718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial.
    Wieruszewski PM; Bellomo R; Busse LW; Ham KR; Zarbock A; Khanna AK; Deane AM; Ostermann M; Wunderink RG; Boldt DW; Kroll S; Greenfeld CR; Hodges T; Chow JH;
    Crit Care; 2023 May; 27(1):175. PubMed ID: 37147690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of angiotensin II in treatment of refractory distributive shock.
    Rodriguez R; Fernandez EM
    Am J Health Syst Pharm; 2019 Jan; 76(2):101-107. PubMed ID: 31361800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.
    Mori J; Zhang L; Oudit GY; Lopaschuk GD
    J Mol Cell Cardiol; 2013 Oct; 63():98-106. PubMed ID: 23886814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of direct renin inhibition versus angiotensin II receptor blockade on angiotensin profiles in non-diabetic chronic kidney disease.
    Antlanger M; Bernhofer S; Kovarik JJ; Kopecky C; Kaltenecker CC; Domenig O; Poglitsch M; Säemann MD
    Ann Med; 2017 Sep; 49(6):525-533. PubMed ID: 28358246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.